# Imiglucerase (Genetical Recombination) for I.V. Injection 400 Units (セレザイム静注用４００単位)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 3959406D2021). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 3959406D2021
- **Product name (Japanese):** セレザイム静注用４００単位
- **English title:** Imiglucerase (Genetical Recombination) for I.V. Injection 400 Units
- **Active ingredient:** イミグルセラーゼ（遺伝子組換え）
- **Active ingredient (INN):** Imiglucerase (Genetical Recombination)
- **Strength / unit:** ４００単位１瓶
- **Route:** Injection (注射薬)
- **Therapeutic category:** 39 Other metabolic agents (その他の代謝性医薬品) › 395 Enzyme preparations (酵素製剤)
- **Manufacturer:** Sanofi (サノフィ)
- **NHI price (reference only):** JPY 256941 per ４００単位１瓶
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/3959406D2021
- **JSON:** https://www.nifujipharma.com/api/drugs/3959406D2021

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Imiglucerase%20(Genetical%20Recombination)%20for%20I.V.%20Injection%20400%20Units%20(%E3%82%BB%E3%83%AC%E3%82%B6%E3%82%A4%E3%83%A0%E9%9D%99%E6%B3%A8%E7%94%A8%EF%BC%94%EF%BC%90%EF%BC%90%E5%8D%98%E4%BD%8D)%20%2F%20YJ%203959406D2021#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.